Lucas GC Ltd. engages in providing recruitment and outsourcing services through its subsidiaries The company was founded by Howard Lee on August 15, 2022 and is headquartered in Beijing, China.

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.

Delta Apparel, Inc. engages in designing, manufacturing, sourcing, and marketing lifestyle branded active wear apparel and headwear. It operates through the Delta Group and Salt Life Group segments. The Delta Group segment consists of the business units DTG2Go, Delta Activewear, and Soffe, which are primarily focused on core activewear styles. The Salt Life Group segment includes lifestyle brands focused on a range of apparel garments, headwear, and related accessories to meet consumer preferences and fashion trends, along with Salt Life and Coast business units. The company was founded in 1999 and is headquartered in Duluth, GA.

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH, GLP-E, and hGh, The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.

Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.

Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.

Shapeways Holdings, Inc. engages in the provision of an end-to-end digital manufacturing platform where digital designs can be transformed into physical products. The company was founded in 2008 and is headquartered in Livonia, MI.

ICZOOM Group, Inc. is an offshore holding company, which engages in conducting operations in China through its subsidiaries and engages in the sales of electronic component. It mainly does business through e-commerce trading platforms and sells two categories of electronic component products-semiconductor products and electronic equipment, tools and other products. The company semiconductor products primarily include various integrated circuit, discrete, passive components, optoelectronics, and equipment, tools and other electronic component products primarily include various electromechanical, maintenance, repair & operations ("MRO"), and various design tool. Its products are widely used by SMEs in the consumer electronic industry, Internet of Things ("IoT"), automotive electronics and industry control segment. The company also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance. The company was founded by Lei Xia and Duan Rong Liu on June 23, 2015 and is headquartered in Shenzhen, China.

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded in 2004 and is headquartered in South San Francisco, CA.